239 related articles for article (PubMed ID: 22234631)
1. Curative strategies for liver metastases from colorectal cancer: a review.
Zdenkowski N; Chen S; van der Westhuizen A; Ackland S
Oncologist; 2012; 17(2):201-11. PubMed ID: 22234631
[TBL] [Abstract][Full Text] [Related]
2. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?
Ihnát P; Vávra P; Zonča P
World J Gastroenterol; 2015 Jun; 21(22):7014-21. PubMed ID: 26078580
[TBL] [Abstract][Full Text] [Related]
3. A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases.
Chun YJ; Kim SG; Lee KW; Cho SH; Kim TW; Baek JY; Park YS; Hong S; Chu CW; Beom SH; Jung M; Shin SJ; Ahn JB
Clin Colorectal Cancer; 2020 Sep; 19(3):e140-e150. PubMed ID: 32402681
[TBL] [Abstract][Full Text] [Related]
4. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases.
Jaeck D; Oussoultzoglou E; Rosso E; Greget M; Weber JC; Bachellier P
Ann Surg; 2004 Dec; 240(6):1037-49; discussion 1049-51. PubMed ID: 15570209
[TBL] [Abstract][Full Text] [Related]
5. R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy.
Tanaka K; Nojiri K; Kumamoto T; Takeda K; Endo I
Eur J Surg Oncol; 2011 Apr; 37(4):336-43. PubMed ID: 21277151
[TBL] [Abstract][Full Text] [Related]
6. Role of adjuvant therapy after resection of colorectal cancer liver metastases.
Power DG; Kemeny NE
J Clin Oncol; 2010 May; 28(13):2300-9. PubMed ID: 20368552
[TBL] [Abstract][Full Text] [Related]
7. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS].
Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA
Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159
[TBL] [Abstract][Full Text] [Related]
8. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy.
Bismuth H; Adam R; Lévi F; Farabos C; Waechter F; Castaing D; Majno P; Engerran L
Ann Surg; 1996 Oct; 224(4):509-20; discussion 520-2. PubMed ID: 8857855
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases.
Okuno M; Hatano E; Kasai Y; Nishio T; Seo S; Taura K; Yasuchika K; Nitta T; Mori A; Okajima H; Kaido T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
Surg Today; 2016 Jun; 46(6):721-8. PubMed ID: 26315324
[TBL] [Abstract][Full Text] [Related]
10. Comparison of oncological outcomes between neoadjuvant and adjuvant chemotherapy combined with surgery for resectable synchronous colorectal liver metastases.
Oh SY; Kim DY; Kim YB; Suh KW
J Surg Res; 2013 Jun; 182(2):257-63. PubMed ID: 23253254
[TBL] [Abstract][Full Text] [Related]
11. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.
Nordlinger B; Sorbye H; Glimelius B; Poston GJ; Schlag PM; Rougier P; Bechstein WO; Primrose JN; Walpole ET; Finch-Jones M; Jaeck D; Mirza D; Parks RW; Mauer M; Tanis E; Van Cutsem E; Scheithauer W; Gruenberger T; ; ; ; ;
Lancet Oncol; 2013 Nov; 14(12):1208-15. PubMed ID: 24120480
[TBL] [Abstract][Full Text] [Related]
12. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.
Andreou A; Knitter S; Schmelzle M; Kradolfer D; Maurer MH; Auer TA; Fehrenbach U; Lachenmayer A; Banz V; Schöning W; Candinas D; Pratschke J; Beldi G
Surgery; 2021 May; 169(5):1061-1068. PubMed ID: 33386128
[TBL] [Abstract][Full Text] [Related]
13. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
[TBL] [Abstract][Full Text] [Related]
14. Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis.
Chaudhury P; Hassanain M; Bouganim N; Salman A; Kavan P; Metrakos P
HPB (Oxford); 2010 Feb; 12(1):37-42. PubMed ID: 20495643
[TBL] [Abstract][Full Text] [Related]
15. [Neoadjuvant chemotherapy as a treatment strategy for multiple bilobar liver metastases from colorectal carcinoma].
Suzuki S; Sakaguchi T; Nakamura T; Nakamura S; Konno H
Nihon Geka Gakkai Zasshi; 2006 May; 107(3):128-32. PubMed ID: 16734269
[TBL] [Abstract][Full Text] [Related]
16. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy before liver resection of colorectal metastases: friend or foe?
Lehmann K; Rickenbacher A; Weber A; Pestalozzi BC; Clavien PA
Ann Surg; 2012 Feb; 255(2):237-47. PubMed ID: 22041509
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens.
Oussoultzoglou E; Romain B; Panaro F; Rosso E; Pessaux P; Bachellier P; Jaeck D
Ann Surg; 2009 Jun; 249(6):879-86. PubMed ID: 19474695
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
